LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immunochromatography Quantifies Prostate Specific Antigen

By LabMedica International staff writers
Posted on 18 Jan 2012
Print article
A fluorescence immunochromatography method using monoclonal antibodies to prostate specific antigen (PSA) has been developed.

The fluorescence immunochromatographic analysis system is composed of anti-PSA-monoclonal antibody (mAb), fluorescence conjugates in a detection solution, a immunochromatographic assay strip, and a laser fluorescence scanner.

Scientists at Kangwon National University (Chuncheon, Korea) have developed a fluorescence immunochromatographic assay strip consists of a nitrocellulose membrane, a sample pad, an absorption pad, and a backing card. The fluorescence immunochromatographic-analysis system was employed to detect PSA based on the area ratio between the control line and the test line of the strip. The test line on the nitrocellulose membrane was dispensed with anti-PSA-mAb; the detection solution was a mixture of anti-PSA-mAb- fluorescent (FL) conjugate and biotin-bovine serum albumin (BSA)-FL conjugate.

Serum obtained from a healthy man, was spiked with PSA to produce five different concentrations: 0.72 ng/mL, 2.3 ng/mL, 4.6 ng/mL, 11.5 ng/mL, 23 ng/mL. These five human sera samples when applied on to the fluorescence immunochromatographic strip which detected PSA concentrations in the human sera samples correlating consistently with the assumed vales. The optimum incubation time of test samples would be exactly 20 minutes, since the standard curve data stored in the fluorescence scanner would be obtained with an incubation time of 20 minutes.

Prostate-specific monoclonal antibody (anti-PSA-mAb) was supplied by Boditech. (Chuncheon, Korea), and prostate-specific antigen (PSA) was obtained from Sigma Aldrich (St. Louis, MO, USA). Under optimal conditions, the area ratio was proportional to PSA concentration ranged from the lowest detection limit of 0.72 ng/mL to 46.0 ng/mL. The authors concluded that as the fluorescence immunochromatography assay is easy to perform and its quantitative range is within PSA concentrations in human blood samples, it shows a potential to be a powerful tool in quantitative analysis of PSA in human blood samples. The study was published in October 2010 in the Journal of Immunoassay and Immunochemistry.

Related Links:
Kangwon National University
Boditech
Sigma Aldrich

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.